We leveraged the role of coal as a major source of energy, increased advanced coal production capacity and stepped up support for power plants and heat-supply enterprises to ensure energy supplies. Despite high global inflation, we have kept overall prices at a comparatively low level, which is ...
Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers needs, the drug will fail to reach its intended ma...
When the global pandemic hit, it disrupted many supply chains. As a result, the delivery of medicines and personal protective equipment were affected. Delays are never reasonable, but they instantly put lives at risk in healthcare. That’s why supply chain managers are trained to find timely s...
The pathogenesis of intestinal inflammation is associated with a combination of genetic and environmental factors that promote an exacerbated immune response, resulting in a continuous and progressive inflammation [3]. The current trend in treatments for IBD patients involves the use of medicines ...
2. Use of medicines in COVID-19 therapy 3. The toxicity of the selected medicines in COVID-19 therapy 4. The toxicity of the selected combinations of medicines in COVID-19 therapy 5. Conclusion and remarks Declaration of competing interest Acknowledgment ReferencesShow full outline Cited by (...
(cohort and case–control studies) published in the last 10 years that evaluated the effect of diabetes medications, namely biguanides, incretin-based medicines, alpha-glucosidase inhibitors (AGIs), insulin secretagogues, thiazolidinediones, and insulins, on the risk of developing any of study ...
The global use of medicines: outlook through (2012), p. 2016 Google Scholar 28 O. Kammona, C. Kiparissides Recent advances in nanocarrier-based mucosal delivery of biomolecules J Control Release, 161 (3) (2012), pp. 781-794 View PDFView articleView in ScopusGoogle Scholar 29 A.A. Kasp...
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. Hepatol. 5, 245–266 (2020). Article Google Scholar Häussinger, D. et al. Hepatic ...
Significant progress has been achieved in human health in the European Union in recent years. New medicines, vaccines, and treatments have been developed to tackle some of the leading causes of disease and life-threatening illnesses. It is clear that inv
Some limiting factors that are expected to restrain the global over the counter drugs market growth in the forecast period are incorrect self-diagnosis leading to the consumption of the wrong medicines. Many OTC cough and cold products have led to medication errors and adverse effects on the patie...